This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: R.p.scherer Technologies, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Linus Gomsi Fonkwe: Innovator in Lipid-Based Dosage Forms
Introduction
Linus Gomsi Fonkwe is a notable inventor based in Clearwater, FL (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of lipid-based dosage forms. His innovative work focuses on enhancing the stability and release profiles of active pharmaceutical ingredients.
Latest Patents
Linus holds a patent for a solid or semisolid lipid-based dosage form stabilization through curing and the addition of low HLB surfactants. This patent, which is crucial for the pharmaceutical industry, discloses dosage forms that comprise a solid or semisolid lipid with immediate and/or extended release properties. The innovative aspect of his work lies in stabilizing the release profile of active pharmaceutical ingredients (APIs) through curing and the incorporation of surfactants with an HLB value of less than 10. He has 1 patent to his name.
Career Highlights
Linus is currently employed at R.P. Scherer Technologies, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work is instrumental in developing more effective and stable drug delivery systems.
Collaborations
Throughout his career, Linus has collaborated with talented professionals, including Monica Lazaro and Irena McGuffy. These collaborations have fostered a creative environment that enhances the development of innovative pharmaceutical solutions.
Conclusion
Linus Gomsi Fonkwe is a pioneering inventor whose work in lipid-based dosage forms is shaping the future of pharmaceutical formulations. His contributions are vital for improving drug delivery systems and enhancing patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
